| Pharmacodynamics of carbamazepine‐mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin MO Magnusson, ML Dahl, J Cederberg, MO Karlsson, R Sandström Clinical Pharmacology & Therapeutics 84 (1), 52-62, 2008 | 104 | 2008 |
| Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment BJ Brennan, K Wang, S Blotner, MO Magnusson, JJ Wilkins, P Martin, ... Antimicrobial agents and chemotherapy 57 (12), 6097-6105, 2013 | 37 | 2013 |
| Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry MO Magnusson, R Sandström Rapid communications in mass spectrometry 18 (10), 1089-1094, 2004 | 29 | 2004 |
| Population pharmacokinetics of a novel once-every 3 months intramuscular formulation of paliperidone palmitate in patients with schizophrenia MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ... Clinical pharmacokinetics 56, 421-433, 2017 | 26 | 2017 |
| Dosing and switching strategies for paliperidone palmitate 3-month formulation in patients with schizophrenia based on population pharmacokinetic modeling and simulation, and … MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ... CNS drugs 31 (4), 273-288, 2017 | 20 | 2017 |
| A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat MO Magnusson, MO Karlsson, R Sandström Pharmaceutical research 23, 521-532, 2006 | 13 | 2006 |
| Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment E Sjögren, J Nyberg, MO Magnusson, H Lennernäs, A Hooker, ... Drug Metabolism and Disposition 39 (5), 858-863, 2011 | 12 | 2011 |
| Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease U Schmid, B Weber, MO Magnusson, M Freiwald Respiratory Medicine 180, 106369, 2021 | 9 | 2021 |
| Population pharmacokinetic modeling of Paliperidone Palmitate 3-month formulation MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ... Population Approach Group in Europe (PAGE) 2015 Meeting, Hersonissos, Greece …, 2015 | 8 | 2015 |
| 1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO M Mirza, D Berton, I Vergote, RD Christensen, A Floquet, J Maenpaa, ... International Journal of Gynecologic Cancer 31 (Suppl 3), 2021 | 6 | 2021 |
| Development of a population pharmacokinetic model of prucalopride in children with functional constipation E van Schaick, MA Benninga, A Levine, M Magnusson, S Troy Pharmacology Research & Perspectives 4 (4), e00236, 2016 | 6 | 2016 |
| PharmTeX: a LaTeX-based open-source platform for automated reporting workflow CH Rasmussen, MK Smith, K Ito, V Sundararajan, MO Magnusson, ... The AAPS Journal 20, 1-11, 2018 | 5 | 2018 |
| Pharmacodynamics of enzyme induction and its consequences for substrate elimination MO Magnusson Acta Universitatis Upsaliensis, 2007 | 5 | 2007 |
| A MECHANISTIC MODEL TO CHARACTERIZE BINDING DYNAMICS OF AMG 102 TO HGF LIGANDS IN CANCER PATIENTS. PO Gisleskog, J Lu, JJ PerezRuixo, MO Magnusson, M Zhu CLINICAL PHARMACOLOGY & THERAPEUTICS 87, S83-S83, 2010 | 4 | 2010 |
| Accuracy of iodine quantification using dual-energy computed tomography with focus on low concentrations A Ahnfelt, P Dahlman, M Segelsjö, MO Magnusson, A Magnusson Acta Radiologica 63 (5), 623-631, 2022 | 3 | 2022 |
| Comparison of quality of urinary bladder filling in CT urography with different doses of furosemide in the work-up of patients with macroscopic hematuria A Ljungberg, M Segelsjö, P Dahlman, M Helenius, M Magnusson, ... Radiography 27 (1), 136-141, 2021 | 3 | 2021 |
| Population pharmacokinetics of tenecteplase in patients with acute myocardial infarction and application to patients with acute ischemic stroke F Tang, J Langenhorst, S Dang, N Kassir, R Owen, B Purdon, ... The Journal of Clinical Pharmacology 63 (2), 197-209, 2023 | 1 | 2023 |
| Translational modeling of regular human insulin pharmacokinetics and glucose dynamics in minipigs Y Lu, O Alskar, MO Magnusson, P Vaddady, E Carballo-Jane, C Valiathan, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 42, S28-S28, 2015 | 1 | 2015 |
| Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus C Acharya, MO Magnusson, P Vajjah, R Oliver, M Zamacona The Journal of Clinical Pharmacology 63 (4), 435-444, 2023 | | 2023 |
| BMS-986036, a PEGylated fibroblast growth factor 21 analogue for the treatment of non-alcoholic steatohepatitis: A population pharmacokinetics and exposure-response analysis G Tirucherai, M Magnusson, C Acharya, E Charles, D Shevell, R Christian, ... Journal of Hepatology 68, S409, 2018 | | 2018 |
